Company overview
-
Bukwang
Pharmaceutical
Company Overview
As of the end of
March 2026
-
- Company Name
- Bukwang
Pharmaceutical
-
- Headquarters
- 7 Sangdo-ro, Dongjak-gu, Seoul, South Korea
-
- CEO
- Jae Young Lee
-
- Founded
- October 17, 1960
-
- Main Business
- Manufacturing and selling
of industry-leading ethical
drugs, over-the-counter
drugs, nutraceuticals,
and personal care
products.
-
- Number of Shares
- 98,664,671 shares
-
- Capital
- KRW 51,506,993,000
-
- Number of Employees
- 611
-
- Website
- www.bukwang.co.kr
* ImmPACT Bio USA Inc. ("ImmPACT"), entered into a merger agreement (Agreement and Plan of Merger) with Lyell
Immunopharma Inc. ("Lyell") on October 24, 2024, making ImmPACT a wholly owned subsidiary of Lyell.